Skip to main content

Pediatric Care

Leo Cancer Care Launches Pediatric Program After First Upright Proton Treatments

Leo Cancer Care Launches Pediatric Program After First Upright Proton Treatments

Boston – September 27, 2026 -- Leo Cancer Care has confirmed a dedicated pediatric program combining education, distraction and gamification technology, following the world's first pediatric treatments delivered on its upright Marie® positioning and imaging platform.

Stanford Medicine delivers first upright pediatric proton treatments in June 2026

Stanford Medicine treated the initial pediatric patients using the Mevion S250-FIT Proton Therapy System, which integrates Leo Cancer Care's Marie platform and RaySearch Laboratories' RayStation planning software. The early cases demonstrated that upright proton therapy is feasible across a wide pediatric age range, with anesthesia still available when clinically required.

Miller Children's Performs First Renata Minima Stent Procedures

Miller Children's Performs First Renata Minima Stent Procedures

Long Beach, Calif. – September 17, 2026 -- The Children's Heart Institute at Miller Children's & Women's Hospital has completed two procedures using the Renata Minima Stent, the first FDA-approved stent system engineered specifically for neonates and infants weighing at least 1.5 kg (3.3 pounds) with pulmonary artery stenosis or coarctation of the aorta.

New stent expands with the patient, reducing repeat surgeries
Unlike conventional stents adapted from adult devices, the Minima Stent can be implanted in infancy and later expanded to accommodate an adult-sized blood vessel, eliminating the need for the stent-replacement surgeries typically required as a child grows.